Your browser doesn't support javascript.
loading
Correction to: Real­world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response.
Ferreira, Amanda Pifano Soares; Seguro, Fernanda Salles; Abdo, Andre Ramires Neder; Santos, Fernanda Maria; Maciel, Felipe Vieira Rodrigues; Nardinelli, Luciana; Giorgi, Ricardo Rodrigues; Ruiz, Antonio Roberto Lancha; Ferreira, Milton Pifano Soares; Rego, Eduardo Magalhaes; Rocha, Vanderson; Bendit, Israel.
  • Ferreira APS; Hematologica Clinic Oncoclinicas, Belo Horizonte, Brazil.
  • Seguro FS; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.
  • Abdo ARN; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.
  • Santos FM; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.
  • Maciel FVR; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.
  • Nardinelli L; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.
  • Giorgi RR; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.
  • Ruiz ARL; Hemato­Oncologia, DASA-Genômica, Sao Paulo, Brazil.
  • Ferreira MPS; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco­Immuno­Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Rego EM; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco­Immuno­Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Rocha V; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.
  • Bendit I; Minas Gerais Federal University, Belo Horizonte, Brazil.
Ann Hematol ; 102(7): 1969, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37160499